Eurospital propose a range of products for identification of patients genetically predisposed to coeliac disease by detecting the following parameters:
It does refer to two different PCR methods, developed and made available by Eurospital R&D. Both technologies identify the main HLA Genotypes predisposing to the development of Coeliac Disease.
Eu-Gen System End-point PCR method on Agarose gel. | XeliGen-RT Real Time PCR method. |